Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05223413 | REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs(RESILIENCE) | recruiting | N/A | 608 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIOTHER | 6 | Sep 18, 2025 | clinicaltrials |
| NCT05643235 | Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors | recruiting | N/A | 50 | Northwell HealthOTHER | 1 | Sep 18, 2025 |
| clinicaltrials |
| NCT06487247 | HEME Home Transfusion Program | recruiting | N/A | 700 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06133426 | Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients(BTP) | recruiting | N/A | 30 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05942885 | Hypnosis: a Path to Appeasement(HYCVA) | recruiting | N/A | 50 | Hospices Civils de LyonOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT04893564 | Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia(SLP-rares) | recruiting | N/A | 90 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | recruiting | N/A | 120 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT06773871 | Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions(HemEx) | recruiting | N/A | 36 | Rigshospitalet, DenmarkOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07126678 | Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma | recruiting | N/A | 15 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07117422 | Venetoclax-Decitabine in Untreated Elderly/Unfit AML | recruiting | N/A | 39 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT06360718 | Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress. | recruiting | N/A | 140 | Children's Hospital Los AngelesOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06386302 | Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia | recruiting | N/A | 184 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT05237258 | Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia(SCOPE-L) | recruiting | N/A | 2,300 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT07085065 | Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies | recruiting | N/A | 365 | Yesmine AmaraOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT07059624 | Femoral Arterial Cannulation in Pediatrics | recruiting | N/A | 80 | American University of Beirut Medical CenterOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07074470 | Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL(VPX) | recruiting | N/A | 40 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07072208 | Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL | recruiting | N/A | 43 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07072221 | Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients | recruiting | N/A | 40 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07059741 | Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL | recruiting | N/A | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT06689917 | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Tongji HospitalOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05255926 | CXCR4-targeted PET/CT Imaging in Hematological Malignancies | recruiting | N/A | 300 | Zhongnan HospitalOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06871176 | PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM) | recruiting | N/A | 30 | University Health Network, TorontoOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT05481502 | An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors(PIONEER) | recruiting | N/A | 160 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT05618041 | The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies | recruiting | N/A | 50 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06785324 | Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)(NEOMA ALL) | recruiting | N/A | 20 | University of ChicagoOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04417803 | Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques(BIOLYMPH2020) | recruiting | N/A | 1,200 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06940960 | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Affiliated Hospital of Guangdong Medical UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT05036564 | Diagnosis; Objective RespOnse; THErApy(DOROTHEA) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04691284 | Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation(SCTMICROBIOM) | recruiting | N/A | 100 | National Cancer Institute, SlovakiaOTHER_GOV | 1 | May 29, 2025 | clinicaltrials |
| NCT04898647 | Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia(SLPRaresHvisc) | recruiting | N/A | 100 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06961669 | Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma(ECAR01) | recruiting | N/A | 18 | Anhui Provincial HospitalOTHER_GOV | 1 | May 29, 2025 | clinicaltrials |
| NCT06890065 | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Shenzhen Genocury Biotech Co., Ltd.INDUSTRY | 1 | May 15, 2025 | clinicaltrials |
| NCT03898596 | Umbilical Vessel Catheterization Under ECG Monitoring and Guidance | recruiting | N/A | 150 | Stanford UniversityOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06946407 | Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma | recruiting | N/A | 41 | FengYan JinOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06947044 | Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding(BAIT) | recruiting | N/A | 60 | Donald ArnoldOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06125483 | TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT | recruiting | N/A | 38 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06699394 | Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis | recruiting | N/A | 20 | Peking University People's HospitalOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT05956457 | PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma | recruiting | N/A | 100 | Pack HealthINDUSTRY | 1 | Apr 20, 2025 | clinicaltrials |
| NCT05793801 | Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia(LEUKA-PICC) | recruiting | N/A | 60 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Apr 14, 2025 | clinicaltrials |
| NCT02964858 | Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.(DOBL) | recruiting | N/A | 840 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2025 | clinicaltrials |
| NCT05945524 | Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination(ResisTec) | recruiting | N/A | 100 | University Hospital, ToulouseOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT03439371 | Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia(MTSA) | recruiting | N/A | 21 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05130138 | Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia(PHARM-LMC) | recruiting | N/A | 100 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05259553 | Biomarkers in Multiple Myeloma(VESICOM) | recruiting | N/A | 70 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06082947 | αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)(TB19DHCT) | recruiting | N/A | 50 | Nationwide Children's HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06885476 | Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients | recruiting | N/A | 22 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06886425 | Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies(CDA-AML-MDS) | recruiting | N/A | 70 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06883604 | Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin(PRO-Hodgkin) | recruiting | N/A | 75 | Uppsala University HospitalOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05475600 | APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU(APAER_H) | recruiting | N/A | 90 | Centre Hospitalier Régional Metz-ThionvilleOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06581081 | Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia | recruiting | N/A | 130 | Peking University People's HospitalOTHER | 1 | Mar 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 18, 2025source: clinicaltrials